Insider · CIK 0001575202

GUJRATHI SHEILA

Reports to the SEC for 8 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001575202

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-28	PCSAProcessa Pharmaceuticals, Inc. · Series A Preferred StockA Award	Director	AAward	+70.8K sh	—	—	70,811.877
2026-07-28	PCSAProcessa Pharmaceuticals, Inc. · Series A Preferred StockA Award	Director	AAward	+12.3K sh	—	—	12,311.279
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.9K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.8K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−278K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−662K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−130K sh	—	—	0
2025-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+3,750 sh	—	—	118,889
2025-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2025-06-05	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-12-23	VTYXVentyx Biosciences, Inc.P Purchase	Director	PPurchase	+130K sh	$2.31	+$301K	130,000
2024-11-05	JANXJanux Therapeutics, Inc.J Other	Director	JOther	+4,611 sh	—	—	115,139
2024-06-26	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,350 sh	—	—	8,350
2024-06-26	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	—	—	110,528
2024-06-06	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	—	—	33,000
2024-02-29	JANXJanux Therapeutics, Inc.J Other	Director	JOther	+2,986 sh	—	—	108,028
2024-01-21	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2023-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-08	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.9K sh	—	—	15,937
2023-03-30	VTYXVentyx Biosciences, Inc.S Sale	Director	SSale	−100K sh	$33.73	−$3.37M	0
2023-03-30	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100K sh	—	—	662,369
2023-03-30	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100K sh	$6.03	+$603K	100,000
2022-12-21	VTYXVentyx Biosciences, Inc.G Gift	Director	GGift	−33K sh	—	—	0
2022-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-06-09	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.8K sh	—	—	21,825
2022-06-09	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,301
2021-12-02	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+278K sh	—	—	277,941
2021-10-25	VTYXVentyx Biosciences, Inc.C Conversion	Director	CConversion	+32.9K sh	—	—	32,897
2021-10-25	VTYXVentyx Biosciences, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−32.9K sh	—	—	0
2020-06-15	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2020-02-14	GOSSGossamer Bio, Inc.A Award	Director, President & CEO	AAward	+190K sh	—	—	189,500
2020-02-14	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+292K sh	—	—	292,000
2019-09-27	GOSSGossamer Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+10K sh	$16.80	+$168K	4,048,242
2019-04-22	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-03-25	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+380K sh	—	—	380,000
2019-02-12	GOSSGossamer Bio, Inc. · Series A Preferred StockC Conversion	Director, President & CEO	CConversion	−223K sh	—	—	0
2019-02-12	GOSSGossamer Bio, Inc. · Series B Preferred StockC Conversion	Director, President & CEO	CConversion	−56K sh	—	—	0
2019-02-12	GOSSGossamer Bio, Inc.C Conversion	Director, President & CEO	CConversion	+62K sh	—	—	4,038,242
2018-05-10	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-10	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-05-19	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	0
2015-12-02	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-08-27	Receptos, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−26.7K sh	$223.90	−$5.97M	0
2015-08-27	Receptos, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−12.5K sh	—	—	0
2015-08-27	Receptos, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−55.4K sh	$190.49	−$10.6M	0
2015-08-27	Receptos, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−129K sh	$213.23	−$27.6M	0
2015-08-25	Receptos, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−121K sh	—	—	12,500

Recent filings

Accepted (ET)
Jul 304
GUJRATHI SHEILA0001575202-26-000011
SEC(opens sec.gov)
Mar 44
GUJRATHI SHEILA0001575202-26-000002
SEC(opens sec.gov)
Jun 134
Gujrathi Sheila0001415889-25-017314
SEC(opens sec.gov)
Jun 64
Gujrathi Sheila0000950170-25-082966
SEC(opens sec.gov)
Dec 264
Gujrathi Sheila0001415889-24-030180
SEC(opens sec.gov)
Nov 74
Gujrathi Sheila0001415889-24-026386
SEC(opens sec.gov)
Jun 284
Gujrathi Sheila0001415889-24-018440
SEC(opens sec.gov)
Jun 74
Gujrathi Sheila0001415889-24-015973
SEC(opens sec.gov)
Mar 44
Gujrathi Sheila0001415889-24-006305
SEC(opens sec.gov)
Jan 234
Gujrathi Sheila0001209191-24-002079
SEC(opens sec.gov)

Companies

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121